Showing results (431-440 of 1,750) with videos related to
Sort By:
Pageof 175
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 29, 2024
Identification of the CD8 + T-cell Related Signature for Predicting the Prognosis of Gastric Cancer Based on Integrated Analysis of Bulk and Single-cell RNA Sequencing DataZhi-Gang Zhu, Zheng Wang, Qiong Wu, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 20, 2024
False-positive Findings of Large Vessel Vasculitis on FDG-PET in Patients Treated With Immune Checkpoint InhibitorsDylan Johnson, Shahin Jamal, Ryan W Hung, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 4, 2024
Multiomics Analysis of Interleukin-21 as a Potential Immunologic and Biomarker in Hepatocellular CarcinomaYonghui Ma, Guanming Shao, Yuwei Xie, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 7, 2024
Vitexin Inhibits TNBC Progression and Metastasis by Modulating Macrophage Polarization Through EGFR SignalingYufeng Lin, Lin Li, Huakang Huang, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 26, 2024
Successful Treatment of Metastatic Primary Cutaneous Adnexal Carcinoma With a PD-1 InhibitorJanmesh D Patel, Vincent J Pozorski, Nika Tavberidze, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 8, 2023
Effect of Concomitant Use of Proton Pump Inhibitors on Immunotherapy Clinical Response in Advanced Cancer Patients: Real-Life SettingLorenzo Cantarelli, Fernando Gutiérrez Nicolás, Sara García Gil, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 9, 2023
Three-Year Overall Survival of Patients With Advanced Non-Small-Cell Lung Cancers With ≥50% PD-L1 Expression Treated With First-Line Pembrolizumab Monotherapy in a Real-World Setting (ESCKEYP GFPC Study)Chantal Decroisette, Laurent Greillier, Hubert Curcio, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 14, 2024
Brief Communication: Combination of an MIP3α-Antigen Fusion Therapeutic DNA Vaccine With Treatments of IFNα and 5-Aza-2'Deoxycytidine Enhances Activated Effector CD8+ T Cells Expressing CD11c in the B16F10 Melanoma ModelKaitlyn Fessler, Jiaqi Zhang, Avinaash K Sandhu, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 14, 2023
Vogt-Koyanagi-Harada-like Syndrome Induced by Checkpoint Inhibitor CemiplimabYe Huang, Farid Khan, Nehali V Saraiya, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 14, 2026
Immune Checkpoint Inhibitor-Associated Hemophagocytic Lymphohistiocytosis: Clinical Presentation and Outcomes in Three PatientsMayte G Martinez-Garza, Effrosyni Apostolidou, Hugo R Lara-Martinez, et al.Pageof 175